EUR-Lex ·

EU corrects fenpyrazamine pesticide residue limits across food and feed

Food-safety and QA teams must test EU-marketed produce against corrected fenpyrazamine residue limits or face non-compliant placing on the market

Change
Commission Regulation (EU) 2026/1339 of 17 June 2026 corrects the maximum residue levels (MRLs) for the pesticide fenpyrazamine in Annex II to Regulation (EC) No 396/2005, replacing the full fenpyrazamine column with corrected values, effective the third day after publication on 18 June 2026.
Why it matters
The correction fixes a clerical error in the sequence of application dates between Regulations (EU) 2019/90 and (EU) 2019/977 that had left the wrong fenpyrazamine MRL set applying since 13 August 2019. The corrected column sets binding limits across fruit, vegetable, cereal, spice, infusion and animal-origin commodities — including 5 mg/kg on apricots and peaches, 3 mg/kg on grapes, strawberries and tomatoes, 0.7 mg/kg on edible-peel cucurbits, 8 mg/kg on leafy salads, and a 0.01 mg/kg default lower limit of analytical determination on all other listed products. The regulation is binding in its entirety and directly applicable in all Member States.
Implications
  • Food-safety and quality-assurance teams at EU producers, importers and distributors of the listed fruit, vegetable and animal-origin commodities must reconcile fenpyrazamine testing thresholds and release specifications against the corrected Annex II column — produce exceeding the corrected MRL cannot lawfully be placed on the EU market.
  • Laboratory and certification teams running pesticide-residue panels must update fenpyrazamine reporting limits to the corrected values, including the 0.01 mg/kg default lower limit of analytical determination, before issuing compliance certificates against EU shipments.
Who is affected
  • Food-safety and QA teams at EU producers, importers and distributors of the affected commodities
  • Pesticide-residue testing laboratories and certification teams issuing EU compliance results
What to watch
  • Third day following publication on 18 June 2026: corrected fenpyrazamine MRLs apply — produce tested against the superseded values must be re-assessed.
View on EUR-Lex
Clarify with AI

Grounded in this brief. 10 free questions left this month.

Start with a decision question — or ask your own below

Clarify with AI — Pro only

You asked:

Clarify turns any brief into answers specific to your role and exposure.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

$29/month · Founding rate, locked for life. Cancel anytime.

Create a free account to keep clarifying

You asked:

You've used your free guest questions for now. A free account gives you more every month and saves your history — or start a Pro trial for unlimited Clarify and real-time alerts.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

Free account: no card, ever. Pro trial: $29/month after 14 days, no card to start, cancel anytime.

Awareness was never the problem. Translation is.

Your team doesn't miss the change — it loses hours turning a 60-page regulator notice into “what do we actually do.” OwlBrief delivers that as a sourced, decision-ready brief the moment a change publishes.

Get the next brief free →
Similar briefs